Trials / Completed
CompletedNCT02147561
A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 280 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of BOTOX® treatment in Korean adults with chronic migraine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin Type A | Botulinum toxin Type A injected across specific head and neck muscles on Day 0. |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2014-05-26
- Last updated
- 2016-05-27
- Results posted
- 2016-05-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02147561. Inclusion in this directory is not an endorsement.